The latest news, trends, analysis, interviews and podcasts from the global food and beverage industry

Danone has announced a €70 million investment in its first French production line for medical nutrition. The majority of the investment, €60 million, will be used to produce nearly 30 recipes of Danone’s Nutricia oral nutritional supplement for patients. The site, located in Steenvoorde, will produce nearly 20 million litres of medical nutrition annually, aiming to improve outcomes and quality of life for patients suffering from disease-related malnutrition, such as cancer. In addition to the production line, Danone plans to invest €10 million in new infrastructure at the Steenvoorde site, featuring a biomass boiler. The boiler is expected to decrease the site's carbon footprint by nearly 70%. Antoine de Saint-Affrique, CEO of Danone, commented: “Nutritional needs change as people grow, age, and face health challenges, and at Danone, we believe that we have a responsibility to help generations live as healthily as possible". "We are continually innovating, investing and utilising our 125 years of expertise to develop products that are adapted to the growing nutritional needs of millions of patients around the world. This investment is also in line with our Renew Danone strategy and shows our commitment to accelerating our adult medical nutrition product offering to meet healthcare demands and serve more patients.”